Where does Deciphera Pharmaceuticals, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Deciphera Pharmaceuticals, LLC ranks #5,274 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Deciphera Pharmaceuticals, LLC hold?

Deciphera Pharmaceuticals, LLC holds 65 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Deciphera Pharmaceuticals, LLC's Innovation Score?

Deciphera Pharmaceuticals, LLC has an Innovation Score of 51.9 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Deciphera Pharmaceuticals, LLC focus on?

Deciphera Pharmaceuticals, LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 56 patents, ranking #313 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Deciphera Pharmaceuticals, LLC's patent grant rate increasing or decreasing?

Deciphera Pharmaceuticals, LLC's recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Deciphera Pharmaceuticals, LLC's patents?

Deciphera Pharmaceuticals, LLC's patents average 13.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Deciphera Pharmaceuticals, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Deciphera Pharmaceuticals, LLC

USPTO PatentsView assignee record - 65 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Deciphera ranks #5,274 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 7 technology areas.

#5,274
of 49,997 US assignees by volume: Top 11%
by Innovation Score (51.9/100): 13.5
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5274 · US Corporation #5,274 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 65 grants
UPPER-Q #5,274/49,997
PHOTO-FINISH Comfort Research
CPC-NARROW A61P · 7 areas
INNOV-PAR 51.9/100
CLAIMS-RICH 13.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Comfort Research, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Deciphera Pharmaceut… · this assignee

52
IGT Global Soulutions · near

52
Qiagen · near

52
Thunder Power New… · near

52
Touchtunes Music · near

52
3D Lighting… · lowest

7

What this shows Deciphera's Innovation Score is 51.9/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Deciphera's grants concentrate

Deciphera Pharmaceuticals, LLC is a focused PatentsView assignee: 7 CPC subclasses with 86.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (17 grants) versus a trough of 4 in 2021. By volume, Deciphera sits between Comfort Research, LLC and Evapco, Inc..

Deciphera's three-year grant acceleration

Deciphera Pharmaceuticals, LLC shows 40 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Comfort Research

65
Cupp Computing AS

65
DRS Network & Ima…

65
Darex

65
Elite Semiconduct…

65
Energy Recovery

65
Envision Aesc Jap…

65
Evapco

65
Deciphera Pharmac… ◀

65

What this shows Deciphera holds 65 patents at rank #5,275, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Deciphera

By rank, the assignees closest to #5,275 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Deciphera's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Deciphera, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Deciphera ranks #313 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (52 here).

IGT Global Soulutions Corporation 52 Qiagen GmbH 52 Thunder Power New Energy Vehicle Development Company Limited 52 Touchtunes Music Company, LLC 52

Similar claim depth

Nearest assignees by average claims per patent (13.5 here).

Himax Display, Inc. 13.5 avg Thyssenkrupp Presta Teccenter AG 13.5 avg Ricoh Imaging Company, Ltd. 13.5 avg PetroChina Company Limited 13.5 avg

Deciphera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Deciphera Pharmaceuticals, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	9.2%
2016	5	7.7%
2021	4	6.2%
2022	10	15.4%
2023	13	20.0%
2024	17	26.2%
2025partial year	10	15.4%

Which technologies does Deciphera Pharmaceuticals, LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 56

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 56

C07D - Heterocyclic Compounds 38

Y02A - Technologies FOR Adaptation TO Climate Change 7

C07K - Peptides 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#5,274

of 49,997 tracked assignees

Innovation Score

51.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Deciphera Pharmaceuticals, LLC's patent record in context - here's where to go next.

Deciphera Pharmaceuticals, LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 86.2% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #5,274 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Deciphera Pharmaceuticals, LLC against Comfort Research, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.